Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gilead Sciences
AddedFeb 13, 2024
UpdatedJun 28, 2026
Gilead Sciences

Gilead Sciences

Public

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.

HQ
Foster City, CA, US
Founded
1987
Overview
Compare
Fundraising
Employees
Website

Gilead Sciences, founded in 1987, is an American biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for critical diseases. The company's core mission is to advance the care of patients suffering from life-threatening illnesses such as HIV, cancer, and inflammatory conditions. Gilead's product portfolio includes antiviral drugs, oncology treatments, and anti-inflammatory medications, with a strong focus on scientific innovation and health equity.

Notable figures associated with Gilead Sciences include its founder Michael L. Riordan and key investors such as BlackRock and Vanguard Group. The company has achieved significant milestones, including the development of groundbreaking antiviral therapies like Remdesivir for COVID-19 treatment. Gilead's impact is profound, having transformed the landscape of antiviral treatment and improved access to essential medicines globally.

Gilead Sciences - Similar Companies

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Genentech logo

Genentech

gene.com

GSK logo

GSK

gsk.com

Rigel Pharmaceuticals logo

Rigel Pharmaceuticals

rigel.com

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Intercept Pharmaceuticals logo

Intercept Pharmaceuticals

AstraZeneca logo

AstraZeneca

astrazeneca.com

Biogen logo

Biogen

biogen.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

AbbVie logo

AbbVie

abbvie.com

Regeneron Ph logo

Regeneron Ph

regeneron.com

Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

vrtx.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

enanta.com

Altiris Therapeutics logo

Altiris Therapeutics

Gilead Sciences - Quick Facts

Who are Gilead Sciences' competitors?

Companies similar to Gilead Sciences include Bristol Myers Squibb, Genentech, GSK and Rigel Pharmaceuticals.

When was Gilead Sciences founded?

Gilead Sciences was founded in 1987.

Where is Gilead Sciences' headquarters located?

Gilead Sciences' headquarters is located in Foster City, CA, US.

When was Gilead Sciences' last funding round?

Gilead Sciences' most recent funding round was for $2B (USD) in September 2023.

How much has Gilead Sciences raised to-date?

As of Sep 7, 2023, Gilead Sciences has raised a total of $2B (USD).

How many employees does Gilead Sciences have?

Gilead Sciences has 17,000 employees as of Feb 6, 2024.

Gilead Sciences - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapies
Tags
  • Healthtech
Unique IDs
  • ein: 943047598
  • secCik: 0000882095
  • ticker: GILD
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research